Ayala Pharmaceuticals OverviewTrack Ayala Pharmaceuticals's total revenue ($690K) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowAs of Dec 2022
Trailing 12 months ending Dec 2022
As of the most recent data (December 2022), AYLA shows a total revenue of $690K. In the prior-year period, the figure was $0. That is below the Healthcare sector average of $110B. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, AYLA's total revenue is now $690K (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Ayala Pharmaceuticals is outperforming or lagging.
The Healthcare sector average total revenue is about $110B. Ayala Pharmaceuticals is at $690K, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how AYLA stacks up against individual peers as well.
Tracking AYLA's total revenue over time shows whether Ayala Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $690K In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this total revenue page, Stockcircle has Ayala Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total revenue (currently $690K) with ownership activity and broader fundamentals.
